NYSE
AMRZ
Last Price
US $53.64
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Amrize Ltd cash flow to debt ratio of 37.39% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
Amrize Ltd's free cash flow has decreased -13.41% from $1.64G last year to $1.42G, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Amrize Ltd's debt to equity ratio is 0.45, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Amrize Ltd's debt has increased relative to shareholder equity from 0.43 last year to 0.45 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
Amrize Ltd has a net debt to EBITDA ratio of 1.42x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial risk - ICR.
Amrize Ltd interest expense data unavailable for the most recent period; interest coverage ratio cannot be reliably computed.
Financial risk - Profit margin growth.
Amrize Ltd's profit margin has decreased (-17.28%) in the last year from 12.12% to 10.03%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Amrize Ltd's short-term assets of $4.68G exceed its short-term liabilities of $2.86G
Decreasing performance - ROA.
Amrize Ltd's return on assets of 4.89% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Amrize Ltd's return on equity of 8.94%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Amrize Ltd's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Amrize Ltd had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Amrize Ltd has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Amrize Ltd has a free cash flow yield of 4.60%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Amrize Ltd's yearly earnings has decreased -16.49% since last year from $1.42G to $1.19G, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Amrize Ltd's yearly revenue has increased 0.95% since last year from $11.70G to $11.81G, signaling increasing performance
Increasing performance - ROIC.
ROIC 6.83% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Amrize Ltd's 3-year revenue CAGR of 3.28% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Amrize Ltd had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Amrize Ltd had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Amrize Ltd has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Amrize Ltd has insufficient data to evaluate this check.
Overvalued - EBITDA valuation.
Amrize Ltd is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Amrize Ltd has an EV/EBITDA ratio of 12.03x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Amrize Ltd has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Amrize Ltd has a price-to-book ratio of 2.26x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Amrize Ltd has a price-to-sales ratio of 2.53x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
8.94%
Return on equity
ROIC: 6.83%
Valuation History
25.3X
Price to Earnings
EV/EBITDA: 12.0X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $53.64
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.